Ribociclib added to endocrine therapy extends survival in postmenopausal metastatic breast cancer patients

How AI will transform mental health support for breast cancer patients, narrative review paper details

Researchers from UVA Cancer Center, the University of Virginia School of Medicine, and Inova Peterson Life with Cancer detail the many ways artificial intelligence could help ensure patients receive the support they need.

September 19, 2025

Vol.51 No.34

In Brief

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Venkata Lokesh BattulaClinton YamA multidisciplinary team of researchers at VCU Massey Comprehensive Cancer Center and MD Anderson Cancer Center has been awarded a $7.3 million grant from the U.S. Department of Defense to fund a novel clinical trial targeting one of the most aggressive and hard-to-treat forms of breast cancer: metastatic triple-negative breast cancer.

September 12, 2025

Vol.51 No.33

Clinical Roundup

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

Natural killer cells became markedly better at killing cancer cells after scientists removed key gene targets identified through a new genome-wide CRISPR screening tool, according to new research from the University of Texas MD Anderson Cancer Center.

September 12, 2025

Vol.51 No.33

Clinical Roundup

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

The MammaPrint, a gene expression profiling test, predicts the benefit of chemotherapy for patients with hormone receptor-positive, HER2-negative early-stage breast cancer, according to findings published in JNCI Cancer Spectrum.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

Cancer cells can break down the protective covers around nerves, causing nerve injury that triggers chronic inflammation leading to immune exhaustion and eventual resistance to immunotherapy, according to a study led by researchers at The University of Texas MD Anderson Cancer Center.

September 05, 2025

Vol.51 No.32

Cancer Policy

ACOG says it will no longer accept federal funding

The American College of Obstetrics and Gynecology said it will no longer be accepting federal funding.

August 08, 2025

Vol.51 No.31

By Claire Marie Porter

Ribociclib added to endocrine therapy extends survival in postmenopausal metastatic breast cancer patients

YOU MAY BE INTERESTED IN

How AI will transform mental health support for breast cancer patients, narrative review paper details

VCU Massey, MD Anderson researchers awarded $7.3M grant to launch breast cancer clinical trial

Novel tool helps identify key targets to strengthen CAR NK cell therapies, MD Anderson research shows

MammaPrint predicts chemotherapy benefit in HR+HER2 early breast cancer patients, observational FLEX study finds

Cancer-associated nerve injury leads to chronic inflammation and immunotherapy resistance

ACOG says it will no longer accept federal funding

Renew today!

Subscriber content

Never miss an issue!

Login